Scancell to Present at the H.C. Wainwright 28th Annual Global Investment Conference
OXFORD, United Kingdom and BURLINGTON, Mass., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Scancell Holdings plc (AIM: SCLP) , a late-stage clinical immuno-oncology company developing active immunotherapies designed to enhance anti-tumor immune responses in difficult-to-treat cancers, announced today that company management will…
Short extract only — this publisher licenses its text. Read the full release at the source.
Free plan · Plus CA$29 or Pro CA$99/month


